Intrinsiqs

Is Amphastar Pharmaceuticals, Inc. overvalued?

Amphastar Pharmaceuticals, Inc. (AMPH) looks undervalued — trading about 48% below its fair value.

Undervalued
Current price $27.39 Fair value $40.49
Price
$27.39
Fair value
$40.49
Current P/E
9.3
Normal P/E
13.8
Market cap
$1.21B
Dividend yield
0.0%
Return on equity
10.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AMPH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated